OKYO Pharma reported total assets of $0.02B and total liabilities of $0.01B for the quarter ended Mar 2026. This balance sheet covers 9 quarters of results from Mar 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Mar2021 | Mar2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current Assets | |||||||||
| Cash & EquivalentsCash & Equiv. | 6.89M | 2.70M | 4.05M | 1.62M | 0.83M | 0.40M | 1.56M | 4.22M | 14.59M |
| Short-term InvestmentsInvestments (Current) | 6.00M | ||||||||
| Cash & Current Investments | 6.89M | 2.70M | 4.05M | 1.62M | 0.83M | 0.40M | 1.56M | 4.22M | 20.59M |
| Receivables - NetNet Receivables | 0.04M | 0.81M | 0.59M | 0.15M | 0.24M | 0.38M | |||
| Receivables - OtherOther Receivables | 0.04M | 0.81M | 0.34M | 0.30M | 0.01M | 0.36M | 0.00M | 0.42M | 0.00M |
| Receivables | 0.09M | 1.63M | 0.93M | 0.16M | 0.25M | 0.38M | |||
| Prepaid Assets | 0.17M | 0.25M | 0.13M | 0.32M | 0.23M | 0.39M | 0.21M | ||
| Current Assets | 6.99M | 4.30M | 5.20M | 2.37M | 1.54M | 2.83M | 3.68M | 4.64M | 20.97M |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
| Intangibles | 98,579.00M | ||||||||
| Goodwill & Intangibles | 98,579.00M | ||||||||
| Other Non-Current Assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||||
| Non-Current Assets | 104,636.00M | 5,225.00M | 7,216.00M | 0.01M | 3,350.00M | 0.00M | 2,035.00M | 0.00M | 6,311.00M |
| Assets | 7.09M | 4.30M | 5.20M | 2.38M | 1.54M | 2.83M | 3.68M | 4.64M | 20.98M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payables | 210.99M | 1.31M | 4.26M | 5.42M | 7.06M | 9.61M | 8.37M | 7.64M | 8.64M |
| Payables | 210.99M | 1.31M | 4.26M | 5.42M | 7.06M | 9.61M | 8.37M | 7.64M | 8.64M |
| Other Accumulated Expenses | 47,041.00M | 0.78M | 0.52M | 0.36M | 0.45M | 0.86M | 0.23M | ||
| Short term Debt | 2.22M | 2.37M | 0.00M | 0.19M | |||||
| Current Leases | 34,148.00M | ||||||||
| Total Current Liabilities | 1.71M | 1.35M | 7.26M | 8.32M | 7.42M | 10.05M | 9.23M | 8.06M | 8.64M |
| Non-Current Liabilities | |||||||||
| Operating Leases | 0.06M | ||||||||
| Other Non-Current Liabilities | 861,214.00M | 53,413.00M | 0.08M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M |
| Total Non-Current Liabilities | -861,212.23M | -53,411.65M | 7.17M | 8.23M | 7.33M | 9.96M | 9.13M | 7.97M | 8.55M |
| Total Liabilities | 1.77M | 1.35M | 7.26M | 8.32M | 7.42M | 10.05M | 9.23M | 8.06M | 8.64M |
| Shareholder's Equity | |||||||||
| Total Debt | 2.22M | 2.37M | 0.00M | 0.19M | |||||
| Common Equity | 5.32M | 2.95M | -2.05M | -5.94M | -5.88M | -7.23M | -5.55M | -3.42M | 12.34M |
| Liabilities and Shareholders Equity | 7.09M | 4.30M | 5.20M | 2.38M | 1.54M | 2.83M | 3.68M | 4.64M | 20.98M |
| Retained Earnings | -106.00M | -112.43M | -125.70M | -134.52M | -142.52M | -145.20M | -143.02M | -145.61M | -152.00M |
Pull OKYO Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=OKYO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "OKYO", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=OKYO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();